Profil
Richard Walovitch was Senior Vice President-Clinical Research of Acusphere, Inc. from 2005 to January 2009 and Vice President-Clinical Research from 1997 to January 2009.
Prior to joining Acusphere, he was Vice President-Pre clinical and Clinical Research at Epix Medical, Inc. from 1993 to 1997 and the International Project Clinician at DuPont Merck Pharmaceutical Company from 1988 to 1993.
Dr. Walovitch received a BS in Biology and a PhD in Pharmacology from the University of Illinois.
Anciens postes connus de Richard Walovitch
| Sociétés | Poste | Fin |
|---|---|---|
| ACUSPHERE, INC. | Directeur Technique/Scientifique/R&D | 08/01/2009 |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Directeur Technique/Scientifique/R&D | 01/01/1997 |
Formation de Richard Walovitch
| University of Illinois | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACUSPHERE, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
